Clinical trial
Topical 5% Imiquimod Cream for Vulvar Paget's Disease: Clinical Efficacy, Safety and Immunological Response
NCT02385188 is registered in ClinicalTrials.gov with University Medical Center Nijmegen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical 5% Imiquimod Cream for Vulvar Paget's Disease: Clinical Efficacy, Safety and Immunological Response
- Lead sponsor
- University Medical Center Nijmegen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- November 30, 2019
- Enrollment
- 25 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.